Effectiveness of Intra-Arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma: Relevance of a Multidisciplinary Setting

References

• Seregard S, Lundell G, Svedberg H, Kivelä T. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis. Ophthalmology. 2004;111(6):1228–1232. doi:10.1016/j.ophtha.2003.10.023
   PubMed Web of Science ®Google Scholar
• Manjandavida FP, Stathopoulos C, Zhang J, Honavar SG, Shields CL. Intra-arterial chemotherapy in retinoblastoma – a paradigm change. Indian J Ophthalmol. 2019;67(6):740–754. doi:10.4103/ijo.IJO
   PubMed Web of Science ®Google Scholar
• Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9(2):69–73. doi:10.1007/s10147-004-0392-6
   PubMedGoogle Scholar
• Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A Phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma. Initial results. Ophthalmology. 2008;115(8):1398–1405. doi:10.1016/j.ophtha.2007.12.014
   PubMed Web of Science ®Google Scholar
• Abruzzo TA, Geller JI, Kimbrough DA, et al. Adjunctive techniques for optimization of ocular hemodynamics in children undergoing ophthalmic artery infusion chemotherapy. J Neurointerv Surg. 2015;7(10):770–776. doi:10.1136/neurintsurg-2014-011295
   PubMed Web of Science ®Google Scholar
• Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117(8):1623–1629. doi:10.1016/j.ophtha.2009.12.030
   PubMed Web of Science ®Google Scholar
• Aziz HA, Boutrid H, Murray TG, et al. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage VB retinoblastoma. Retina. 2010;30(4SUPPL. 4):63–65. doi:10.1097/IAE.0b013e3181cbda0f
   PubMedGoogle Scholar
• Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011;129(11):1399–1406. doi:10.1001/archophthalmol.2011.150
   PubMedGoogle Scholar
• Thampi S, Hetts SW, Cooke DL, et al. Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution. Clin Ophthalmol. 2013;7:981–989. doi:10.2147/OPTH.S43398
   PubMedGoogle Scholar
• Gobin YP. Intra-arterial chemotherapy for the management of retinoblastoma. Arch Ophthalmol. 2011;129(6):732. doi:10.1001/archophthalmol.2011.5
   PubMed Web of Science ®Google Scholar
• Shields CL, Dockery PW, Yaghy A, et al. Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1292 infusions): comparative analysis of outcomes based on patient age, race, and sex. J AAPOS. 2021;25(3):150.e1–e150.e9. doi:10.1016/j.jaapos.2020.12.006
   PubMed Web of Science ®Google Scholar
• Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg. 2011;114(6):1603–1608. doi:10.3171/2011.1.JNS10466
   PubMed Web of Science ®Google Scholar
• Abramson DH, Marr BP, Dunkel IJ, et al. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-Year results. Br J Ophthalmol. 2012;96(4):499–502. doi:10.1136/bjophthalmol-2011-300498
   PubMed Web of Science ®Google Scholar
• Shields CL, Kaliki S, Shah SU, Bianciotto CG, Jabbour P. Effect of intraarterial chemotherapy on retinal detachment. Retina. 2012;32(4):799–804.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang B, Dong Y, et al. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age. BMC Cancer. 2019;19(1):1–8. doi:10.1186/s12885-019-5844-5
   PubMedGoogle Scholar
• Abramson DH, Marr BP, Francis JH, et al. Simultaneous bilateral ophthalmic artery chemosurgery for bilateral retinoblastoma (tandem therapy). PLoS One. 2016:1–11. doi:10.1371/journal.pone.0156806
   Web of Science ®Google Scholar
• Say EAT, Iyer PG, Hasanreisoglu M, et al. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes. J AAPOS. 2016;20(4):337–342. doi:10.1016/j.jaapos.2016.05.009
   PubMed Web of Science ®Google Scholar
• Li J, Jing C, Hua X, et al. Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma. Eye. 2021. doi:10.1038/s41433-021-01693-w
   Web of Science ®Google Scholar
• Mirzayev I, Gündüz AK, Yavuz K, et al. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma. Eur J Ophthalmol. 2021;31(5):2692–2698. doi:10.1177/1120672120957587
   PubMed Web of Science ®Google Scholar
• Hua J, Gang S, Yizhou J, Jing Z. Intra-arterial chemotherapy as second-line treatment retinoblastoma: a 2-year single-center study in China for advanced. J Cancer Res Ther. 2019;1:106–110.
   Google Scholar
• Abramson DH, Shields CL, Munier FL, Chantada GL. Treatment of retinoblastoma in 2015: agreement and disagreement. JAMA Ophthalmol. 2015;133(11):1–7. doi:10.1001/jamaophthalmol.2015.3108
   Web of Science ®Google Scholar
• Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol. 2006;17(3):228–234. doi:10.1097/01.icu.0000193079.55240.18
   PubMed Web of Science ®Google Scholar
• Brodie SE, Abramson DH, Navarro BV. Success of intra-arterial chemotherapy (chemosurgery) for retinoblastoma. J Proteom. 2015;130(2):180–185. doi:10.1016/j.jprot.2015.09.027
   PubMedGoogle Scholar
• Gobin YP, Dunkel IJ, Marr BP, Francis JH, Brodie SE, Abramson DH. Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma. PLoS One. 2012;7(9):e44322. doi:10.1371/journal.pone.0044322
   PubMed Web of Science ®Google Scholar
• Abramson DH, Dunkel IJ, Brodie SE, Marr B, Pierre Gobin Y. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Archiv Ophthalmol. 2016;128(3):370–372.
   Google Scholar
• Michaels ST, Abruzzo TA, Augsburger JJ, Correˆa M, Lane A, Geller JI. For advanced intraocular retinoblastoma: cchmc early experience. J Pediatr Hematol/Oncol. 2016;38(1):65–69. doi:10.1097/MPH.0000000000000471
   PubMed Web of Science ®Google Scholar
• Abramson DH, Fabius AWM, Issa R, et al. Advanced Unilateral retinoblastoma: the impact of ophthalmic artery chemosurgery on enucleation rate and patient Survival at MSKCC. PloS One. 2015;2009:1–9. doi:10.1371/journal.pone.0145436
   Google Scholar
• Ravindran K, Dalvin LA, Pulido JS, Brinjikji W. Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis. J Neurointerv Surg. 2019;11(12):1266–1272. doi:10.1136/neurintsurg-2019-014909
   PubMed Web of Science ®Google Scholar
• Gündüz AK, Mirzayev I, Dinçaslan H, Özalp Ateş FS. Recurrence and new tumor development after frontline intravenous chemotherapy for retinoblastoma: risk factors and treatment results. Eur J Ophthalmol. 2022;32(3):1795–1803. doi:10.1177/11206721211023311
   PubMed Web of Science ®Google Scholar
• Francis JH, Roosipu N, Levin AM, et al. Current treatment of bilateral retinoblastoma: the impact of intraarterial and intravitreous chemotherapy. Neoplasia. 2018;20(8):757–763. doi:10.1016/j.neo.2018.05.007
   PubMed Web of Science ®Google Scholar
• Francis JH, Levin AM, Zabor EC, Gobin YP, Abramson H. Ten-year experience with ophthalmic artery chemosurgery: ocular and recurrence-free survival. PLoS One. 2018;13(5):1–17.
   Web of Science ®Google Scholar